Carsten Brunn
President, CEO & Chairman of the Board at Cartesian Therapeutics (NASDAQ: RNAC)
Watertown, Massachusetts, United States
Find your path to Carsten
383 people in our graph share verified history with Carsten — schools, employers, funds. One of them is your warm intro.
Vincent RoseunlockedCarsten: together at Bayer (2017)
×9Carsten: together at Bayer
×2Carsten: together at University of Hamburg
About
Carsten Brunn serves as President and CEO of Cartesian Therapeutics. He has more than 25 years of leadership experience across the Americas, Europe, and Asia-Pacific, including roles at two NASDAQ-listed biotechnology companies, and has secured over $500 million in capital. His work spans therapeutic areas such as mRNA cell therapy, immune tolerance, and rare diseases.
President, CEO & Chairman of the Board at Cartesian Therapeutics (NASDAQ: RNAC)
Intro paths
→
In turn, Carsten can intro founders to Cartesian Therapeutics (NASDAQ: RNAC)'s investors below.
Cartesian Therapeutics (NASDAQ: RNAC)'s investors · 8
Co-founders at Cartesian Therapeutics (NASDAQ: RNAC)
MK
Metin KurtogluExecutive Officer
OF
Omid FarokhzadDirector
Experience
- Cartesian TherapeuticsPresident and CEOcurrent2023 — presentFrederick, Maryland, United States
- Selecta BiosciencesPresident and CEO2018 — 2023
- BayerPresident Region Americas2017 — 2018Whippany, New Jersey
- BayerPresident Bayer Yakuhin2013 — 2016Osaka, Japan
- BayerGlobal Head Primary Care2011 — 2012Beijing, China
- Bausch + LombVice President Pharma Asia Pacific2009 — 2010Singapore
- Basilea Pharmaceutica InternationalGlobal Head of Marketing2008 — 2009
- NovartisGlobal Brand Director2005 — 2008
- Eli Lilly and CompanyGlobal Product Team1998 — 2005USA
Frequently asked questions
- Who is Carsten Brunn?
- Carsten Brunn serves as President and CEO of Cartesian Therapeutics. He has more than 25 years of leadership experience across the Americas, Europe, and Asia-Pacific, including roles at two NASDAQ-listed biotechnology companies, and has secured over $500 million in capital. His work spans therapeutic areas such as mRNA cell therapy, immune tolerance, and rare diseases.
- Where does Carsten Brunn work?
- Carsten Brunn is President, CEO & Chairman of the Board at Cartesian Therapeutics (NASDAQ: RNAC).
- Where did Carsten Brunn go to school?
- Carsten Brunn studied at University of Hamburg (Doctor of Philosophy - PhD, Chemistry); London Business School (Accelerated Development Program); The University of Freiburg (Master's degree, Pharmaceutical Sciences).
Same school
Also attended University of Hamburg91
Andreas WeiskamPartner and Co-Founder of Sapphire Ventures, focused on European investmentsLucas De FourLegal Manager at Hummingbird VenturesFernanda BartelsInvestor at Extantia CapitalAndrew KozlovManaging Partner at 4BIO CapitalJennifer SchoeberleinPartner, ESG & Impact at Sawari VenturesIskender DirikPartner at Delin Ventures
+ 85 more
Also attended London Business School906
Patrick ClaessenPartner at Cottonwood Technology FundDominic JacquessonInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMatt CherianVenture Partner at Monta Vista CapitalAkshat GoenkaInvestor at Moonfire VenturesGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 900 more
Also attended The University of Freiburg78
Ruth Foxe BladerInvestor at Citrine VentureDr. Elias Börgmann-DehinaGeneral Counsel & Portfolio Manager at HeadlineJens LapinskiFounding Partner at Angel InvestChristina UlardicPartner at Astanor VenturesMaik FechnerVenture Partner at Blockchain Founders CapitalJan BeckerInvestment Team at 10x Founders
+ 72 more
Also attended University of Washington608
Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesJoe HorsmanInvestor at Madrona Venture Group
+ 602 more
Shared employers
Also worked at Cartesian Therapeutics3
Also worked at Selecta Biosciences5
Aymeric SallinFounder and CEO at +ND CapitalAlex ColvilleCo-Founder, General Partner at age1Blaine DavisExecutive Officer at Cartesian Therapeutics (NASDAQ: RNAC)Lloyd JohnstonExecutive Officer at Cartesian Therapeutics (NASDAQ: RNAC)Peter G TraberExecutive Officer, Director at Galectin Therapeutics
Also worked at Bayer149
Vincent RoseInvestment Manager at Burda Principal InvestmentsBenjamin BrockwellVenture Partner at Copper Sky CapitalAxel BouchonVenture Partner at ARCH Venture PartnersVincent RulandEntrepreneur-in-Residence at Versant VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersMelike Abacioglu GunesVP of Marketing at Asymmetric Capital Partners
+ 143 more
